Practice
Featured experience
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal sale of ownership in NBC Sports Washington to MSE
We are advising Comcast and NBCUniversal on the transaction
Veoneer sale of Restraint Control Systems business to AIP
We are advising Veoneer and SSW Partners on the sale
Cadre acquisition by Yieldstreet
We are advising Cadre on the transaction
Lightyear Capital strategic investment in Inszone Insurance
We are advising Lightyear Capital on the strategic investment and related financing arrangements
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Ferrara Candy acquisition of Jelly Belly Candy
We are advising Ferrara on the acquisition